William Sahlman, the senior associate dean for external relations at Harvard Business School, wrote an excellent op-ed in the Boston Globe yesterday. We couldn’t agree more with his assessment of the dreadful funding environment for scientific research.  His piece helps us understand the difficulties of making productive progress in disease research by taking a look at how research labs work. While this piece was inspired by the recent stem-cell research issue, it is applicable to most research including Alzheimer’s.

Read the op-ed in the Boston Globe>